Related Articles
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin‑bound paclitaxel for human epidermal growth factor receptor 2‑negative breast cancer
Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide
ADVANCED BREAST-CANCER - A RANDOMIZED STUDY OF DIFFERENT DOSES OF EPIRUBICIN ASSOCIATED WITH FIXED DOSES OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.